Page 5 - An Evidence Review of Active Surveillance in Men With Localized Prostate Cancer

Acknowledgments

We would like to acknowledge the help and constructive comments provided by members of
the Technical Expert Panel and peer reviewers in bringing this report to fruition.

Technical Expert Panel
Hans-Olov Adami, M.D., Ph.D. Deborah Kuban, M.D.
Harvard School of Public Health The University of Texas MD Anderson
Boston, MA Cancer Center
Houston, TX
Patricia Ganz, M.D.
University of California Los Angeles School Daniel W. Lin, M.D.
of Public Health University of Washington
Los Angeles, CA Seattle, WA

Paul Godley, M.D., Ph.D. Daniel A. Ollendorf, M.P.H.
University of North Carolina at Chapel Hill Institute for Clinical and Economic Review
Chapel Hill, NC Boston, MA

Robert B. Hicks, Esq. Peter T. Scardino, M.D.
Patient Representative Memorial Sloan-Kettering Cancer Center
New York, NY

Invited Peer Reviewers

Michael Barry, Ph.D. Julia Hayes, M.D.
Massachusetts General Hospital Dana-Farber Cancer Institute
Boston, MA Boston, MA

Justin Bekelman, M.D. Eric Klein, M.D.
Hospital of the University of Pennsylvania Glickman Urological & Kidney Institute,
Philadelphia, PA Cleveland Clinic
Cleveland, OH
Matthew Cooperberg, M.D., M.P.H.
Hospital of the University of California, San Steven Pearson, M.D.
Francisco Institute for Clinical and Economic Review
San Francisco, CA Boston, MA

Mark Soloway, M.D.
University of Miami School of Medicine
Miami, FL

v